Michael Schaeffer
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-04-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Algemeen Directeur | 01-03-2016 |
SiREEN AG
SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Algemeen Directeur | 01-01-2004 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
SiREEN AG
SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Commercial Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau